您好，欢迎来到易推广！ 请登录 免费注册

上海陶术生物科技有限公司 主营产品：生物试剂,实验服务等

当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示

企业档案

会员类型：会员

已获得易推广信誉   等级评定
139成长值

(0 -40)基础信誉积累，可浏览访问

(41-90)良好信誉积累，可接洽商谈

(91+  )优质信誉积累，可持续信赖

易推广会员：5年

工商认证 【已认证】

最后认证时间：

注册号： 【已认证】

法人代表： 【已认证】

企业类型：生产商 【已认证】

注册资金：人民币万 【已认证】

产品数：86101

参观次数：3498129

手机网站：http://m.yituig.com/c135739/

旗舰版地址：http://tsbiochem.app17.com

自主品牌

自主品牌

已选条件

  • T76700Simtuzumab；辛妥珠单抗GS 6624|||AB 0024；GS 6624|||AB 0024

    Simtuzumab is a monoclonal antibody against lysyl oxidase-like protein 2 (LOXL2). Simtuzumab can be used to treat primary sclerosing cholangitis (PSC) and is not effective in patients with bridging fibrosis or compensatory cirrhosis caused by non-alcoholic steatohepatitis.

    价 格：￥电议型 号：T76700产 地：中国大陆

  • T76699Sabatolimab；Sabatolimab单抗MBG453|||NVP-MBG453；MBG453|||NVP-MBG453

    Sabatolimab (MBG453), a humanized IgG4 (S228P) antibody targeting TIM-3, is a potent inhibitory receptor that regulates adaptive and innate immune responses. Sabatolimab has potential immunosuppressive activity and selectively binds to TIM-3 on immune cells and bone marrow cells.

    价 格：￥电议型 号：T76699产 地：中国大陆

  • T76698Rovalpituzumab；洛伐妥珠单抗Rovalpituzumab

    Rovalpituzumab is a humanized monoclonal antibody targeting delta-like protein 3 (DLL3). Rovalpituzumab can be used to synthesize antibody-active molecule conjugates (ADCs). Rovalpituzumab has anticancer activity and is used to treat small cell lung cancer (SCLC).

    价 格：￥电议型 号：T76698产 地：中国大陆

  • T76697Panitumumab (anti-EGFR)；化合物 Panitumumab (anti-EGFR)Panitumumab (anti-EGFR)

    Panitumumab, a fully human IgG2 anti-EGFR monoclonal antibody, exerts anti-tumor effects by inhibiting tumor cell proliferation, survival, and angiogenesis. It is utilized in researching various cancers, including colon cancer [1] [2] [4].

    价 格：￥电议型 号：T76697产 地：中国大陆

  • T76696Onvatilimab；奥瓦利单抗JNJ-61610588；JNJ-61610588

    Onvatilimab (JNJ-61610588) is a human IgG1 κ-anti-Vista (T-cell-activated V-domain Ig inhibitor) monoclonal antibody. Onvatilimab has antitumor activity and can be used to treat advanced head and neck cancers.

    价 格：￥电议型 号：T76696产 地：中国大陆

  • T76695Oleclumab；化合物 OleclumabOleclumab

    Oleclumab (MEDI9447), a human IgG1λ monoclonal antibody, targets and inhibits CD73 functionality, demonstrating anti-tumor activity [1].

    价 格：￥电议型 号：T76695产 地：中国大陆

  • T76694Odronextamab；化合物 OdronextamabOdronextamab

    Odronextamab, a fully human, hinge-stabilized IgG4-based bispecific antibody, targets CD3 receptors on T cells and CD20 receptors on B cells [1].

    价 格：￥电议型 号：T76694产 地：中国大陆

  • T76693Moxetumomab；化合物 MoxetumomabMoxetumomab

    Moxetumomab, a recombinant immunotoxin targeting CD22, is utilized in the study of hairy cell leukemia (HCL) [1] [2].

    价 格：￥电议型 号：T76693产 地：中国大陆

  • T76692Mosunetuzumab；莫妥珠单抗BTCT-4465A；BTCT-4465A

    Mosunetuzumab (BCT-4465A) is a humanized antibody based on immunoglobulin G1 that targets CD20 (B cells) and CD3 (T cells). Mosunetuzumab redirects T cells to engage and eliminate malignant B cells and can be used to study relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL) and refractory follicular lymphoma.

    价 格：￥电议型 号：T76692产 地：中国大陆

  • T76691Monalizumab；莫那利珠单抗Monalizumab

    Monalizumab is a novel immune checkpoint inhibitor targeting natural killer cell population 2A (NKG2A). Monalizumab is a humanized monoclonal antibody against NKG2A that induces IFN-γ production, thereby activating natural killer cell function. Monalizumab has antitumor activity and can be used to study neck squamous cell carcinoma (HNSCC).

    价 格：￥电议型 号：T76691产 地：中国大陆

  • T76690Mavrilimumab；玛弗利木单抗CAM 3001；CAM 3001

    Mavrilimumab (CAM 3001) is a monoclonal antibody with antiviral activity that has an affinity for the α subunit of the granulocytic-macrophage colony-stimulating factor (GM-CSF) receptor and blocks downstream intracellular signaling of GM-CSF. GM-CSF may be associated with an overactive inflammatory response associated with respiratory failure and death, and could be used to study rheumatoid arthritis.

    价 格：￥电议型 号：T76690产 地：中国大陆

  • T76689Margetuximab；化合物 MargetuximabMargetuximab

    Margetuximab (MGAH22) is a chimeric anti-HER2 monoclonal antibody with an optimized Fc domain, exhibiting an EC50 value of 39.33 ng/mL. It is utilized in the research of metastatic HER2-positive breast cancer [1].

    价 格：￥电议型 号：T76689产 地：中国大陆

  • T76687Ibalizumab；艾巴利珠单抗TNX-355|||TMB-355；TNX-355|||TMB-355

    Ibalizumab(TMB-355) is a humanized IgG4 monoclonal antibody that acts as a CD4 receptor inhibitor, blocking the entry of HIV-1 into cells by binding to the CD4 receptor.Ibalizumab has anti-HIV-1 infectious activity and may be used to maintain normal immune function.

    价 格：￥电议型 号：T76687产 地：中国大陆

  • T76686Lebrikizumab；化合物 LebrikizumabLebrikizumab

    Lebrikizumab, an IgG4 humanized monoclonal antibody, specifically targets and inhibits interleukin-13 (IL-13), thus impacting its function. This compound is utilized in asthma research [1].

    价 格：￥电议型 号：T76686产 地：中国大陆

  • T76685Glofitamab；格菲妥单抗RO7082859|||RG 6026|||CD20-TCB；RO7082859|||RG 6026|||CD20-TCB

    Glofitamab (RO7082859) is a novel bivalent antibody directed against CD20-binding T cells.Glofitamab promotes T cell proliferation and activation and tumor cell killing by binding to CD20 on malignant cells.Glofitamab can be used for the palliation of relapsed or refractory B-cell lymphomas.

    价 格：￥电议型 号：T76685产 地：中国大陆

  • T76684Girentuximab；吉妥昔单抗cG250|||WX-G250|||G250；cG250|||WX-G250|||G250

    Girentuximab (G250) is a potent anti-carbonic anhydrase IX (CAIX) monoclonal antibody with anticancer activity for the study of uroepithelial carcinoma PET (ZiPUP).

    价 格：￥电议型 号：T76684产 地：中国大陆

  • T76683Gantenerumab；化合物 GantenerumabGantenerumab

    Gantenerumab, a fully human IgG1 monoclonal antibody targeting amyloid-β (Aβ), exhibits sustained binding to cerebral Aβ. It is employed in research focused on Alzheimer´s disease [1].

    价 格：￥电议型 号：T76683产 地：中国大陆

  • T76682Galcanezumab；加那珠单抗LY 2951742；LY 2951742

    Galcanezumab is a humanized IgG4 monoclonal antibody targeting the CGRP ligand, which binds to the ligand calcitonin gene-related peptide. Galcanezumab can be used to prevent and treat migraines or cluster headaches.

    价 格：￥电议型 号：T76682产 地：中国大陆

  • T76681Fresolimumab；非苏木单抗GC1008；GC1008

    Fresolimumab (GC1008) is a specific human anti-transforming growth factor β monoclonal antibody that binds to the active forms of human TGFβ1, TGFβ2, and TGFβ3 and can be used to study focal segmental glomerulosclerosis and cancer in adults.

    价 格：￥电议型 号：T76681产 地：中国大陆

  • T76680Fremanezumab；化合物 FremanezumabFremanezumab

    Fremanezumab (TEV-48125), a humanized IgG2a monoclonal antibody, potently and selectively targets the calcitonin gene-related peptide (CGRP), a 37-amino acid neuropeptide implicated in the central and peripheral mechanisms of migraine. It holds promise for research into chronic migraine treatment [1].

    价 格：￥电议型 号：T76680产 地：中国大陆

132333435363738394041下一页共41页

展台首页| 公司简介| 供应产品| 产品目录| 公司动态| 荣誉证书| 招聘信息| 技术中心| 联系我们| 会员管理

易推广  设计制作，未经允许翻录必究.Copyright(C) 2009 http://www.yituig.com, All rights reserved.

以上信息由企业自行提供，信息内容的真实性、准确性和合法性由相关企业负责，易推广对此不承担任何责任.   总访问量：3498129

中国彩虹热线

快速导航

返回顶部
在线咨询

提交